News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Pharmaceutical Press

Advertisement

Articles by Pharmaceutical Press

Learn how Pharmaceutical Excipients through MedicinesComplete can transform the way you work

Learn how Pharmaceutical Excipients through MedicinesComplete can transform the way you work

ByPharmaceutical Press
September 22nd 2025

Webinar Date/Time: Thu, Oct 9, 2025 11:00 AM EDT

Advertisement

Latest Updated Articles

  • Learn how Pharmaceutical Excipients through MedicinesComplete can transform the way you work
    Learn how Pharmaceutical Excipients through MedicinesComplete can transform the way you work

    Published: September 22nd 2025 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

BioMarin Reaches $4.8 Billion Definitive Agreement to Acquire Amicus Therapeutics

2

President Trump Announces Nine More TrumpRx Participants

3

Senate Passes Biosecure Act

4

Eli Lilly Announces Topline Results From Phase III Trial Studying Oral GLP-1 Therapy Orforglipron

5

The End of the Rebate Era? What HR Leaders and Pharmacy Consultants Need to Know About Biosimilars

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us